Practice Management
A large study in the Journal of the American College of Cardiology found that 99% of those who experience heart attacks and strokes have at least 1 of the 4 biggest risk factors. By tracking health records for more than a decade in more than 9.3 million adults in South Korea and nearly 7,000 adults in the United States, researchers found that virtually all subjects had at least 1 major cardiovascular risk factor beforehand, and …
Read More
Children with elevated blood pressure in childhood can experience a greater risk of early death from cardiovascular disease (CVD) in adulthood, a new long-term study in JAMA finds. At baseline, 21% of the 37,081 children studied were classified as having hypertension, while about 19% were classified as having elevated blood pressure. Participants (born from 1959 to 1966) were followed to a median age of 54 years. At follow-up, a 1-SD higher systolic blood pressure measure …
Read More
The seemingly ubiquitous Apple smartwatch now has another feature that could be useful in screening users for health conditions. In addition to its approved method for alerting users for possible atrial fibrillation, the latest version of the wearable device includes a tool to detect chronic hypertension, according to the company’s press release. The watch would display a heart-shaped symbol and a “possible hypertension” notification based on data from an optical heart sensor that analyzes how …
Read More
Recent updates to blood pressure (BP) guidelines published in the Journal of the American College of Cardiology have lowered the threshold for initiating hypertension treatment among low-risk patients. According to the 2025 joint guideline from the American Heart Association and the American College of Cardiology, adults without clinical cardiovascular disease (CVD) and with an estimated 10-year CVD risk below 7.5% should begin antihypertensive therapy if their average systolic BP remains at 130 mm Hg or …
Read More
The Food and Drug Administration (FDA) has approved a new polypill that combines telmisartan, amlodipine, and indapamide for the treatment of hypertension in adults, including use as an initial therapy. This is the first FDA-approved triple-combination medication indicated for initial use in patients who are likely to require multiple drugs to reach their blood pressure goals, according to a press release from manufacturer George Medicines. Most patients with hypertension ultimately need 2 or more medications …
Read More
Evaluating Interventions for Improving Antibiotic Stewardship in Urgent Care Take Home Point: An antibiotic stewardship intervention was associated with reduced rates of antibiotic prescribing for patients with bronchitis, but not viral upper respiratory infections (URI). Citation: Park D, Roberts A, Hamdy R, et. al. Evaluating an urgent care antibiotic stewardship intervention: a multi-network collaborative effort. Infect Control Hosp Epidemiol. 2025; Jan 8:1-6. doi: 10.1017/ice.2024.213 Relevance: Antibiotic prescribing for conditions not caused by bacterial infection remains …
Read More
A 65-year-old female with a history of hypertension presents with chest pain and dyspnea for 1 day. She denies fever, cough, nausea, vomiting, or abdominal pain. Upon arrival to urgent care, her respiratory rate was 28 breaths per minute, blood pressure 179/102, and oxygen saturation 92% on room air. An ECG is obtained. View the ECG captured above and consider what your diagnosis and next steps would be. Resolution of the case is described on …
Read More
A study in the Journal of the American Heart Association found that young individuals with hypertension may benefit from low-level tragus stimulation (LL‐TS). The device-based therapy is a noninvasive method of tragus stimulation with an ear clip, targeting the auricular branch of the vagus nerve. In the small study of 40 patients aged 18 to 39 years, LL‐TS was applied on the intervention group (IG) for 3 months on the tragus (20 Hz, 1 mA, 1 hour per day). …
Read More
Last week, the Food and Drug Administration approved the medication sotatercept, which traps activins that cause constriction of arteries in the lungs, leading to pulmonary arterial hypertension (PAH). Sotatercept targets a growth factor that is overproduced in PAH, reducing the risk of blood vessel thickening. The population with PAH is relatively small—diagnosed in 500 to 1,000 Americans annually and disproportionately affecting women between the ages of 30 and 60, according to the American Lung Association. …
Read More
In a study presented in JAMA Network Open, researchers sought to determine the difference in the long-term risk of mortality and morbidity outcomes for adults with hypertension taking a thiazide-type diuretic, calcium channel blocker (CCB), or angiotensin-converting enzyme (ACE) inhibitor. Their secondary analysis found that mortality due to cardiovascular disease was similar among patients, regardless of which treatment was used. However, compared with the diuretic group, the ACE inhibitor group had a 19% increased risk …
Read More